Table 1.
Clinical & demographic profile of study participants.
| Group |
Moderate |
Severe |
All COVID-19 |
Healthy Control |
|
|---|---|---|---|---|---|
| Study Participants | 20 | 22 | 42 | 10 | |
| Gender | Male | 15 (75) | 14 (63.6) | 29 (69) | 5 (50) |
| Female | 5 (25) | 8 (36.4) | 13 (30.9) | 5 (50) | |
| CORAD Score | CORADS 4 | 6 (30) | 3 (13.6) | 9 (21.4) | 0 (0) |
| CORADS 5 | 14 (70) | 19 (86.4) | 33 (78.6) | ||
| CTSS | ≤10 | 12 (60) | 0 (0) | 12 (28.6) | 0 (0) |
| >10 - ≤ 20 | 8 (40) | 16 (72.7) | 24 (57.1) | ||
| >20 - ≤ 25 | 0 (0) | 6 (27.3) | 6 (14.3) | ||
| Symptoms | Fever | 15 (75) | 15 (68.2) | 30 (71.4) | 0 (0) |
| Cold | 2 (10) | 1 (4.5) | 3 (7.1) | ||
| Cough | 7 (35) | 9 (40.9) | 16 (38.1) | ||
| Breathlessness | 9 (45) | 12 (54.5) | 21 (50) | ||
| Loss of taste & Smell | 2 (10) | 8 (36.4) | 10 (23.8) | ||
| Common Comorbidities | Hypertension | 5 (25) | 9 (40.9) | 14 (33.3) | 0 (0) |
| Diabetes Mellitus |
5 (25) |
9 (40.9) |
14 (33.3) |
||
| Deceased | 0 (0) | 3 (13.6) | 3 (7.1) | 0 (0) | |
| Platelet Count | 191500 (150750–252750) | 223000 (183000–275000) | 199000 (155500–265000) | 227189 (189500–275000) | |
| Ferritin | 243.5 (47–445.8) | 303 (151.5–713) | 287 (118–546.5) | 256 (204.4–296) | |
| D-Dimer (DOA) μg/mL | 0.561 (0.361–0.729) | 0.878 (0.682–1.891) | 0.732 (0.467–1.157) | 0.312 (0.289–0.355) | |
| D-Dimer (Day 7) μg/mL | 0.66 (0.395–1.768) | 1.085 (0.889–1.523) | 0.975 (0.51–1.523) | – | |
Data are represented in n (%) and median (IQR).